Discontinuation of long-term proton pump inhibitor treatment
Ugeskrift for Læger · 02.03.2026 · 1-3
DOI: 10.61409/v08250629 ↗Kurz gefasst
Fallbericht in der Zeitschrift Ugeskrift for Læger, online erschienen am 02.03.2026. Verfasst von Peter Fentz Haastrup und 1 weiteren Autor:innen. Beteiligte Einrichtung: Lægerne i Hesselager. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Pantoprazole. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
This case report describes a 69-year-old woman on long-term pantoprazole therapy, initially prescribed for nonspecific upper gastrointestinal symptoms. Despite resistance to discontinuation due to rebound symptoms, a gradual dose reduction combined with patient education and use of antacids led to successful cessation. The case highlights the importance of regular medication review, patient involvement, and awareness of rebound acid hypersecretion in facilitating rational PPI use and deprescribing efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lægerne i Hesselager.
- Forskningsenheden for Almen Praksis, Institut for Sundhedstjenesteforskning, Syddansk Universitet.
Zitieren
APA
Haastrup, P. F., & Jarbøl, D. E. (2026). Discontinuation of long-term proton pump inhibitor treatment. Ugeskrift for Læger, 1-3. https://doi.org/10.61409/v08250629
Vancouver
Haastrup PF, Jarbøl DE. Discontinuation of long-term proton pump inhibitor treatment. Ugeskrift for Læger. 2026:1-3. doi:10.61409/v08250629
BibTeX
@article{Haastrup2026,
author = {Haastrup, Peter Fentz and Jarbøl, Dorte Ejg},
title = {Discontinuation of long-term proton pump inhibitor treatment},
journal = {Ugeskrift for Læger},
year = {2026},
pages = {1--3},
doi = {10.61409/v08250629}
}
EUVIMED